Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | QL-XII-61 | GDSC1000 | pan-cancer | AAC | 0.021 | 0.7 |
mRNA | UNC1215 | GDSC1000 | pan-cancer | AAC | 0.015 | 0.7 |
mRNA | erismodegib | CTRPv2 | pan-cancer | AAC | 0.017 | 0.7 |
mRNA | SB 216763 | GDSC1000 | pan-cancer | AAC | 0.017 | 0.7 |
mRNA | BIRB 0796 | FIMM | pan-cancer | AAC | 0.081 | 0.7 |
mRNA | Erlotinib | CCLE | pan-cancer | AAC | 0.02 | 0.7 |
mRNA | BRD-K86535717 | CTRPv2 | pan-cancer | AAC | -0.031 | 0.7 |
mRNA | MS-275 | gCSI | pan-cancer | AAC | 0.023 | 0.7 |
mRNA | SZ4TA2 | CTRPv2 | pan-cancer | AAC | 0.024 | 0.7 |
mRNA | UNC0638 | CTRPv2 | pan-cancer | AAC | 0.016 | 0.7 |